Skip to main content
. Author manuscript; available in PMC: 2016 Feb 9.
Published in final edited form as: Am J Cardiol. 2015 Sep 10;116(11):1752–1755. doi: 10.1016/j.amjcard.2015.08.042

Figure 2.

Figure 2

Change in LVEF in each bilirubin group. The y axis is a percentage scale; open bars reflect the mean decrease in LVEF (in percent), and gray bars reflect the percentage of patients with cancer in each group who sustained >15% decrease in their LVEF. Patients with bilirubin levels at the upper end of the normal range are less likely to have >15% loss of LV ejection fraction after A-bC compared with those at the lower end of the spectrum. “*” and “ψ,” p <0.05 when group 1 is compared with group 3.